Advertisement

Recurrent community-acquired Clostridium(Clostridioides)difficile infection in Serbianchildren

  • Stojanovic PredragEmail author
  • Ed J. Kuijper
  • Stojanović Nikola
  • Karuna E. W. Vendrik
  • Radulović Niko
Original Article
  • 13 Downloads

Abstract

Information on recurrent Clostridium difficile infections (rCDI) in children is rare and limited, especially community acquired (CA-CDI).This study was designed to identify risk factors for rCA-CDI in Serbian pediatric population. The study group included 71 children (aged from 1 to 14 years) with a first episode of CDI. Data were collected from 56 (78.87%) children with only one episode of CA-CDI and from 15 (21.13%) children with rCA-CDI were mutually compared. The following parameters were found to be statistically significantly more frequent in the children with rCA-CDI group (p < 0.05); leukemia as underlying disease, treatment with immunosuppressive and-or cytostatic drugs, and treatment with antibiotics. Similarly, previously visits to outpatient facilities, daycare hospitals and hospitals were also associated with rCDI. Analysis of clinical symptoms and laboratory parameters, revealed a statistically significant association of the severity of the first episode of CDI (determined by an increase in body temperature, higher maximum WBC and higher CRP) with development of a rCDI. Ribotype (RT) 027 was more common in children with rCA-CDI (66.7%, p = 0.006). During the seven-year research period, we found a rate of rCA-CDI rate in children of 21.13%. Our study identified several parameters statistically significantly more frequently in children with rCA-CDI. The obtained results will serve as a basis for future larger studies, but new prospective, studies are necessary to build a prediction model of rCDI in children that can be used to guide the treatment to prevent rCDI.

Keywords

Clostridium difficile Recurrent CDI Community acquired diarrhea Children Diarrhea 

Notes

Acknowledgements

We thank mrs. Celine Harmanus, technician of the National Reference Laboratory Clostridium difficile Leiden University, The Netherlands, for assistance in designing of ribotyping Clostridium difficile isolates.

Funding Information

This study was funded by the Ministry of Education, Science and Technological Development of Serbia [Projects No. 172061].

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Was obtained from parents of all participants included in the study.

References

  1. 1.
    Khanna S, Baddour LM, Huskins WC, Kammer PP, Faubion WA, Zinsmeister AR et al (2013) The epidemiology of Clostridium difficile infection in children: a population – based study. Clin Infect Dis 56(10):1401–1406CrossRefGoogle Scholar
  2. 2.
    Khanna S, Pardi D, Aronson S, Kammer P, Orenstein R, Sauver J et al (2012) The epidemiology of community-acquired Clostridium difficile infection: a population – based study. Am J Gastroenterol 107:89–95CrossRefGoogle Scholar
  3. 3.
    Pant C, Deshpande D, Altaf MA, Minocha A, Sferra T (2013) Clostridium difficile infection in children: a comprehensive review. Curr Med Res Opin 29(8):967–984CrossRefGoogle Scholar
  4. 4.
    Sandora TJ, Fung M, Flaherty K et al (2011) Epidemiology and risk factors for Clostridiumdifficile infetions in children. Pediatr Infect Dis J 30:580–584CrossRefGoogle Scholar
  5. 5.
    Abou Chakra CN, Pepin J, Sirard S, Valiquette L (2014) Risk factors for recurrence, complications and mortality in Clostridium difficile infetion: a systematic review. PLoS One 9(6):e98400CrossRefGoogle Scholar
  6. 6.
    Schwab E, Wilkes J, Korgenski K, Herah A, Pavia A, Stevens V (2016) Risk factors for recurrent Clostridium difficile infection in pediatric inpatients. Hosp Pediatr 6:339–344CrossRefGoogle Scholar
  7. 7.
    Tschudin-Sutter S, Tamma P, Milstone A, Perl T (2014) Predictors of first recurrence of Clostridium difficile infection in children. Pediatr Infect Dis J 33:414–416CrossRefGoogle Scholar
  8. 8.
    Garey KW, Sethi S, Yadav Y, DuPont HL (2008) Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 70:298–304CrossRefGoogle Scholar
  9. 9.
    Rao K, Higgins P, Young V (2018) An observational cohort study of Clostridium difficile ribotype 027 and recurrent infection. mSphere 3:\CrossRefGoogle Scholar
  10. 10.
    Kociolek L, Palac H, Patel S, Shulman S, Gerding D (2015) Risk factors for recurrent Clostridium difficile infection in children: a nested case-control study. J Pediatr 167:384–389CrossRefGoogle Scholar
  11. 11.
    Nicholson M, Thomsen I, Slaughter J, Creech CB, Edwards K (2015) Novel risk factors for recurrent Clostridium difficile infection in children. J Pediatr Gastroenterol Nutr 60:18–22CrossRefGoogle Scholar
  12. 12.
    Nicholson M, Crews J, Starke J, Jiang Z, DuPont H, Edwards K (2017) Recurrent Clostridium difficile infection in children: patient risk factors and markers of intestinal inflammation. Pediatr Infect Dis J 36:379–383CrossRefGoogle Scholar
  13. 13.
    Borali E, Ortisi G, Moretti C, Stacul E, Liprere R, Gesu G, Giacomo C (2015) Community-acquired Clostridium difficile infection in children: a retrospective study. Dig Liver Dis 47:842–846CrossRefGoogle Scholar
  14. 14.
    Predrag S, Branislava K, Nikola S, Niko R, Zorica SR, Stanković-Đorđević D (2018) Community-acquired Clostridium difficile infection in Serbian pediatric population. Eur J Clin Microbiol Infect Dis 37(6):1061–1069CrossRefGoogle Scholar
  15. 15.
    Bidet P, Lalande V, Salauze B, Burghoffer B, Avesani V, Delmée M, Rossier A, Barbut F, Petit JC (2000) Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 38(7):2484–2487PubMedPubMedCentralGoogle Scholar
  16. 16.
    van Dorp SM, Smajlović E, Knetsch CW, Notermans DW, de Greeff SC, Kuijper EJ (2017) Clinical and microbiological characteristics of Clostridium difficile infection among hospitalized children in the Netherlands. Clin Infect Dis 64(2):192–198CrossRefGoogle Scholar
  17. 17.
    Kuijper EJ, Coignard B, Tull P (2006) Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12:2–18CrossRefGoogle Scholar
  18. 18.
    Antonara S, Leber AL (2016) Diagnosis of Clostridium difficile infections in children. J Clin Microbiol 54(6):1425–1433CrossRefGoogle Scholar
  19. 19.
    Schulze GE, Willoughby RE (2013) Committee on infectious diseases; American Academy of pediatrics. Clostridium difficile infection in infants and children. Pediatrics 131(1):196–200CrossRefGoogle Scholar
  20. 20.
    Santiago B, Guerra L, Garcia-Morin M, Gonzalez E, Gonzalvez A, Martos A et al (2015) Clostridium difficile in children hospitalized with diarrhea. An Pediatr (Barc) 82(6):417–425CrossRefGoogle Scholar
  21. 21.
    Ruuska T, Vesikari T (1990) Rotavirus disease in Finnish children: use of numerical scores for clinical clinical severity of diarrhoeal episodes. Scand J Infect Dis 22:259–267CrossRefGoogle Scholar
  22. 22.
    Crobach MJ, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, Wilcox MH, Kuijper EJ (2016) European society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 22(Suppl 4):S63–S81CrossRefGoogle Scholar
  23. 23.
    Benson L, Song X, Campos J, Singh N (2007) Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol 28(11):1233–1235CrossRefGoogle Scholar
  24. 24.
    Crews J, Anderson L, Waller K, Swartz M, DuPont H, Starke J (2015) Risk factors for community-associated Clostridium difficile asociated diarrhea in children. Pediatr Infect Dis J 34:919–923CrossRefGoogle Scholar
  25. 25.
    Hong W, Cheng Y, Rao F, Yang J, Cui G, Chen Z et al (2018) Co-infection of Clostridioides (Clostridium) difficile GMU1 and Bacillus cereus GMU2 in one patient in Guizhou, China. Anaerobe 54:159–163CrossRefGoogle Scholar
  26. 26.
    Stokely JN, Niendorf S, Taube S, Hoehne M, Young VB, Rogers MA et al (2016) Prevalence of human norovirus and Clostridium difficile co-infections in adult hospitalized patients. Clin Epidemiol 28(8):253–260Google Scholar
  27. 27.
    de Graaf H, Pai S, Burns DA, Karas JA, Enoch DA, Faust SN (2015) Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature. Eur J Clin Microbiol Infect Dis 34(7):1281–1287CrossRefGoogle Scholar
  28. 28.
    Kim J, Shaklee JF, Smathers S et al (2012) Risk factors and outcomes associated with severe Clostridium difficile infection in children. Pediatr Infect Dis J 31:134–138CrossRefGoogle Scholar
  29. 29.
    Hojsak I, Ferenc T, Bojanić K, Mišak Z, Močić Pavić A, Lukić-Grlić A et al (2012) Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients. Digestion 86(1):6–11CrossRefGoogle Scholar
  30. 30.
    Fisher BT, Sammons JS, Li Y, de Blank P, Seif AE, Huang YS et al (2014) Variation in risk of hospital-onset Clostridium difficile infection across β-lactam antibiotics in children with new-onset acute lymphoblastic leukemia. J Pediatric Infect Dis Soc 3(4):329–335CrossRefGoogle Scholar
  31. 31.
    Kyne L, Warny M, Qamar A, Kelly CP (2001) Association between antibody response to toxin a and protection against recurrent Clostridium difficilediarrhoea. Lancet 20(357 (9251)):189–193CrossRefGoogle Scholar
  32. 32.
    Adams DJ, Eberly MD, Rajnik M, Nylund CM (2017) Risk factors for community-associated Clostridium difficile infection in children. J Pediatr 186:105–109CrossRefGoogle Scholar
  33. 33.
    Brow KA, Khanafer N, Danemen N, Fisman DN (2013) Meta –analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother 57:2326–2332CrossRefGoogle Scholar
  34. 34.
    Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, LC MD, Society for Healthcare Epidemiology of America, Infectious Diseases Society of America et al (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31(5):431–455CrossRefGoogle Scholar
  35. 35.
    Petrella LA, Sambol SP, Cheknis A, Nagaro K, Kean Y, Sears PS et al (2012) Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 55(3):351–357CrossRefGoogle Scholar
  36. 36.
    Marsh JW, Arora R, Schlackman JL, Shutt KA, Curry SR, Harrison LH (2012) Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol 50(12):4078–4082CrossRefGoogle Scholar
  37. 37.
    Pichenot M, Héquette-Ruz R, Le Guern R, Grandbastien B, Charlet C, Wallet F et al (2017) Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University hospital. Infection 45(4):425–431CrossRefGoogle Scholar
  38. 38.
    Centers for DiseaseControl and Prevention (CDC) (2005) Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. MMWR Morb Mortal Wkly Rep 2(54(47)):1201–1205Google Scholar
  39. 39.
    El Feghaly RE, Stauber JL, Deych E, Gonzalez C, Tarr PI, Haslam DB (2013) Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis 56(12):1713–1721CrossRefGoogle Scholar
  40. 40.
    Cobo J, Merino E, Martínez C, Cózar-Llistó A, Shaw E, Marrodán T, Calbo E, Bereciartúa E et al (2018) Nosocomial infection study group. Prediction of recurrent Clostridium difficile infection at the bedside: the GEIH-CDI score. Int J Antimicrob Agents 51(3):393–398CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Faculty of MedicineUniversity of NišNišSerbia
  2. 2.National Reference Laboratory for Anaerobic Infections - Clostridium difficile, Center of MicrobiologyInstitute for Public Health NisNišSerbia
  3. 3.Department of Medical Microbiology, Center for Infectious Diseases, National Reference Laboratory Clostridium difficile, National Institute of Public Health and the EnvironmentLeiden University Medical CenterLeidenThe Netherlands
  4. 4.Department of Chemistry, Faculty of Science and MathematicsUniversity of NišNišSerbia

Personalised recommendations